We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
VMD launches campaign on protecting UK waterways from contamination from flea and tick treatments
The VMD has published new guidance on packaging, pack size and product information requirements for products intended to be distributed at AVM-GSL.
The new adverse event reporting service from the VMD will replace the previous suspended service.
New drive could help reduce environmental impact
First published during the 2024 to 2026 Starmer Labour government
Product defect recall alert for Scabigard Suspension for Cutaneous Administration - Vm 42058/5173 and Vm 60021/3020 by Zoetis Belgium S.A.
Recall alert for specific batches of Hibiwash due to potential risk of microbial contamination with Burkholderia cepacia complex (BCC).
Change to the information provided on adverse events for Profender Modified-release Tablets, Profender Spot-on Solution and Profender Multi-dose Spot-on Solution in the SPC.
Change to the information provided in the Summary of Product Characteristics for Bioestrovet Swine 0.0875 mg/ml Solution for Injection for Pigs.
Routine update to adverse event data for L2 and L4 dog vaccines, and reminder for vets to tailor vaccination programmes for individual animals.
First Inspections and Enforcement report, covering October and November 2025, providing animal owners, vet practices and other animal health businesses messages on how to remain compliant with the law.
Results from inspections and enforcement activities October-November 2025.
From March 2026, applicants using the Veterinary Medicines Digital Service (VMDS) will only be able to select valid, authorised reference products for certain application types.
VMD in-depth assessment confirms continued positive benefit-risk balance for Librela.
Change to the information provided on adverse events in the Summary of Product Characteristics (SPC).
The VMD is inviting applications from veterinary students to attend a one-week EMS placement in July 2026.
Businesses advertising non-medicinal veterinary products to benefit from updated guidance on marketing non-medicinal veterinary products legally.
VMD introduces new surveillance scheme and updates mock-up assessment requirements to streamline regulation whilst maintaining standards.
UK and Canadian regulatory authorities have signed an agreement to enhance collaboration and improve access to animal vaccines.
Supply Coordination Forum launched to mitigate any delivery risk to Northern Ireland’s veterinary medicine supply
VMD has published webinars to help veterinary professionals, wholesalers and retailers prepare for changes to the supply of veterinary medicines into Northern Ireland.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).